<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">378861417</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180305123347.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161128e20030101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1351/pac200375111881</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)gruyter-10.1351/pac200375111881</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Pharmaceuticals and personal care products - A source of endocrine disruption in the environment?</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[F. Ingerslev, E. Vaclavik, B. Halling-Sørensen]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">A wide variety of chemicals are used in pharmaceuticals. Most of these are already under thorough control for endocrine activity. The main causal agents recognized for endocrine disruption from sewage are substances used in medicine (sex hormones, glucocorticoids, and others), natural substances (estrone and 17β-estradiol), and synthetic estrogens (e.g., 17α-ethinylestradiol). Similar substances are used in anabolic agents (growth hormones) in livestock production in some countries. Although the estimated use of anabolic agents in livestock production is approximately one order of magnitude below the natural release of estrogens from farm animals, their possible significance remains unanswered. At present, no other medical substances are recognized as endocrine disruptors in the environment. However, candidates may be identified on the basis of simple assumptions regarding their use and activity: (1) Nonestrogenic steroids may react with environmental endocrine receptors or metabolize on their way to the environment and thus form endocrine disruptors. (2) Many high-volume drugs released to the environment have not yet been tested for their endocrine properties, and some of these are known to interact with the human endocrine system. (3) Compared to medicinal substances, personal care products and additives in drugs are used in high amounts; from this group, parabens, siloxanes, and other substances are suspected of causing endocrine disruption in the environment.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 2013 Walter de Gruyter GmbH, Berlin/Boston</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ingerslev</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vaclavik</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Halling-Sørensen</subfield>
   <subfield code="D">B.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Pure and Applied Chemistry</subfield>
   <subfield code="d">De Gruyter</subfield>
   <subfield code="g">75/11-12(2003-01-01), 1881-1893</subfield>
   <subfield code="x">0033-4545</subfield>
   <subfield code="q">75:11-12&lt;1881</subfield>
   <subfield code="1">2003</subfield>
   <subfield code="2">75</subfield>
   <subfield code="o">pac</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1351/pac200375111881</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1351/pac200375111881</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ingerslev</subfield>
   <subfield code="D">F.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Vaclavik</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Halling-Sørensen</subfield>
   <subfield code="D">B.</subfield>
   <subfield code="u">The Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen 2100, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Pure and Applied Chemistry</subfield>
   <subfield code="d">De Gruyter</subfield>
   <subfield code="g">75/11-12(2003-01-01), 1881-1893</subfield>
   <subfield code="x">0033-4545</subfield>
   <subfield code="q">75:11-12&lt;1881</subfield>
   <subfield code="1">2003</subfield>
   <subfield code="2">75</subfield>
   <subfield code="o">pac</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="b">CC0</subfield>
   <subfield code="u">http://creativecommons.org/publicdomain/zero/1.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-gruyter</subfield>
  </datafield>
 </record>
</collection>
